X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sclerosteosis (91) 91
index medicus (78) 78
humans (70) 70
female (37) 37
male (37) 37
endocrinology & metabolism (29) 29
sclerostin (27) 27
sost gene (24) 24
osteoporosis (23) 23
density (21) 21
van buchem disease (21) 21
adult (20) 20
sost (20) 20
van-buchem-disease (20) 20
animals (18) 18
genetics & heredity (17) 17
protein (17) 17
genetic aspects (16) 16
radiography (15) 15
bone morphogenetic proteins - genetics (14) 14
chromosome 17q12-q21 (14) 14
genetic markers - genetics (14) 14
orthopedics (14) 14
bone density (13) 13
middle aged (13) 13
osteopetrosis (13) 13
aged (12) 12
bmp antagonist (12) 12
bone morphogenetic proteins - metabolism (12) 12
bones (12) 12
deletion (12) 12
hyperostosis - genetics (12) 12
disease (11) 11
gene (11) 11
genetic markers (11) 11
mice (11) 11
mutation (11) 11
osteogenesis (11) 11
base sequence (10) 10
child (10) 10
genes (10) 10
hyperostosis (10) 10
hyperostosis corticalis generalisata (10) 10
mutations (10) 10
osteosclerosis - genetics (10) 10
bone diseases, developmental - genetics (9) 9
hyperostosis - pathology (9) 9
medicine & public health (9) 9
pedigree (9) 9
signal transduction (9) 9
adolescent (8) 8
biochemistry & molecular biology (8) 8
bone and bones - metabolism (8) 8
bone resorption (8) 8
genetics (8) 8
molecular sequence data (8) 8
osteocyte (8) 8
receptor-related protein-5 (8) 8
abridged index medicus (7) 7
analysis (7) 7
article (7) 7
bone density - genetics (7) 7
bone formation (7) 7
bone morphogenetic proteins (7) 7
cell biology (7) 7
dna mutational analysis (7) 7
dysplasia (7) 7
lrp5 (7) 7
mineral density (7) 7
osteoblasts (7) 7
radiology, nuclear medicine & medical imaging (7) 7
research (7) 7
affected individuals (6) 6
amino acid sequence (6) 6
bone diseases (6) 6
bone dysplasia (6) 6
bone mineral density (6) 6
camurati-engelmann-disease (6) 6
child, preschool (6) 6
diagnosis, differential (6) 6
expression (6) 6
genetic disorders (6) 6
high bone mass (6) 6
identification (6) 6
physiological aspects (6) 6
postmenopausal women (6) 6
wnt signaling (6) 6
bone diseases - genetics (5) 5
bone diseases, developmental - diagnostic imaging (5) 5
bone diseases, developmental - pathology (5) 5
bone-formation (5) 5
chromosome mapping (5) 5
deficiency (5) 5
endocrinology (5) 5
family (5) 5
hyperostosis - diagnostic imaging (5) 5
hyperostosis - physiopathology (5) 5
medical genetics (5) 5
mutation, missense (5) 5
osteoblast (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Zhao, B and Zhao, WQ and Wang, YQ and Zhao, Z and Zhao, CF and Wang, S and Gao, CZ
PLOS ONE, ISSN 1932-6203, 08/2018, Volume 13, Issue 8
Zoledronic acid (ZA) exerts complex influence on bone by suppressing bone resorption, mostly due to the direct osteoclasts inhibition and uncertain influence... 
CBFA1/RUNX2 | CELLS | APOPTOSIS | IN-VITRO | BONE METABOLISM | MULTIDISCIPLINARY SCIENCES | SOST | DIFFERENTIATION | SCLEROSTEOSIS | EXPRESSION | OSTEOPOROSIS
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 15, pp. 1417 - 1427
Among postmenopausal women with osteoporosis and a high risk of fracture, treatment with the monoclonal antibody romosozumab for 12 months followed by... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | BONE-MINERAL DENSITY | VERTEBRAL FRACTURES | DISEASE | AORTA | RANDOMIZED-TRIAL | RISK | STRENGTH | POSTMENOPAUSAL WOMEN | SCLEROSTEOSIS | Humans | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Risk | Bone Remodeling - drug effects | Alendronate - therapeutic use | Incidence | Spinal Fractures - prevention & control | Female | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Alendronate - adverse effects | Bone Density - drug effects | Alendronate - pharmacology | Least-Squares Analysis | Aged | Cardiovascular Diseases - chemically induced | Fractures, Bone - prevention & control | Treatment outcome | Care and treatment | Fractures | Growth | Analysis | Monoclonal antibodies | Bones | Research | Jaw | Femur | Vertebrae | Immunoglobulins | Inhibitor drugs | Osteonecrosis | SOST protein | Bisphosphonates | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Bone growth | Bone density | Drug therapy | Osteogenesis | Index Medicus | Abridged Index Medicus | randomized-trial | metaanalysis | disease | postmenopausal women | strength | bone-mineral density | Klinisk medicin | vertebral fractures | sclerosteosis | Clinical Medicine | aorta | risk | General & Internal Medicine
Journal Article
Journal Article
CLINICAL GENETICS, ISSN 0009-9163, 04/2007, Volume 71, Issue 4, pp. 311 - 319
Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal. We... 
pain | ERYTHERMALGIA | SCLEROSTEOSIS | SENSORY NEURONS | INSENSITIVITY | mutation | SODIUM-CHANNEL BLOCKERS | genetics | sodium channel | CIP (congenital indifference to pain) | SCN9A | AUTONOMIC NEUROPATHIES | GENETICS & HEREDITY | DISORDER | HSAN | LINKAGE ANALYSIS | Na(v)1.7 | ANALGESIA
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2006, Volume 21, Issue 6, pp. 934 - 945
Journal Article